Biotechnology, Pharmaceutical and Healthcare Company and Supplier Directory/Listing

15:06 EDT 21st May 2018 | BioPortfolio

The BioPortfolio Corporate directory has been designed for three groups of users; the professional executive; the researcher; and the general investor.  The directory lists over 40,000 healthcare, pharmaceutical and biotechnology companies worldwide, involved in research, development, manufacturing and related services.  Companies can be sorted by keyword and each profile provides related press releases and clinical trials - for example Cancer Companies.

Corporates & NGOs - how to subscribe to ensure your profile is up-to-date with the latest news and products?

BioPortfolio provides a unique window to the global audience of business professionals, corporate and public researchers, and consumers with an appetite for biotechnology, pharmaceutical and healthcare information.  As a BioCorportate subscriber BioPortfolio will work with you via a dedicated account manager to ensure that we optimize relevant information on your organization published on the site:

  • maintain your corporate profile - upto 500 words, images, URLs etc eg Genentech Inc
  • promote your products and services - upto 10 entries each with a unique Channel web page eg Vantictumab
  • publication of your press releases - upto 20 press releases can be submitted for review and publication - see BioNewsCast
  • your RSS feeds - events, press, blogs etc added to our global news service
  • social media - weekly tweets to our targeted Twitter accounts


Showing Companies 1–25 of 54,000+

Monday 21st May 2018

Sesen Bio, Inc.

The Ulmer Institute

NantOmics, LLC

NantOmics, a member of the NantWorks ecosystem of companies, delivers molecular analysis capabilities with the intent of providing actionable intelligence and molecularly driven decision support for cancer patients and their providers at the point of care. NantOmics is the first molecular testing company to pioneer an integrated approach to unearthing the ...

Wavemaker Three-Sixty Health, L.P.

Dial BioSciences

Dial Environmental is the parent company to Dial Pest Control®, Dial Lawn Watch®, Dial Moldcure Pro® and Dial BioSciences®. Headquartered in Roseland, New Jersey, Dial Environmental specializes in providing families peace of mind by integrating technology with environmental responsibility to achieve greener lawns and pest and mold-free environm...

Oncology Nursing News

The Oncology Nursing News® website provides the latest news and clinical insights for oncology nursing professionals, plus live meeting coverage, video interviews and blog posts from your peers.

Scioto Biosciences

Based in Indianapolis, Indiana, Scioto Biosciences is a preclinical stage company developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics. The Scioto Platform has the potential to enhance efficacy wherever probiotics are used such as diabetes, neurological disorders, gastrointestinal health, alte...


Shenzhen Salubris Pharmaceuticals Co., Ltd. (Salubris) is a publicly traded, fully integrated pharmaceutical company [002294:CH]. Founded in 1998, Salubris has grown to achieve sales of >$750M USD in 2017. Salubris is headquartered in Shenzhen, China, and has over 3,800 employees working across R&D, regulatory, marketing and sales. Its marketed products in...

Great Lakes Caring

Great Lakes Caring Home Health and Hospice is one of the nation’s leading providers of a continuum of home health and hospice care. Great Lakes Caring dedicates its resources to providing value-based, high quality care wherever our patients call home. Great Lakes Caring’s primary focus is to provide superior quality health care to those we are ho...

Galecto Biotech AB

Galectin-3 is a member of the galectin family of galactoside binding lectins. Galectin-3 exists both intra- and extracellularly and binds to glycosylated proteins. Galectin-3 has been shown to play a central role in fibrosis development and progression. The activation of macrophages, and recruitment and activation of myofibroblasts, the two central cell ty...

Portal Instruments

Portal Instruments is a medical device company focused on advanced drug delivery and backed by strategic and venture investors. Portal Instruments is developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic diseases. Real time...

Longboat Clinical

Longboat is a clinical trials software company dedicated to generating better study outcomes by creating a complete support structure for site staff, patients, monitors, and study teams - where protocol compliance becomes easy and instinctive. In the complex world of clinical development, Longboat’s cloud-based site and patient engagement platform emp...

LiveOak Venture Partners

LiveOak is a venture capital fund based in Austin, TX founded by Ben Scott, Krishna Srinivasan, and Venu Shamapant. With over 18 years of successful venture investing in Texas, the founders of LiveOak have helped create over $1.5 billion of enterprise value in exits. While almost all of LiveOak's investments begin in the early stages, LiveOak is a full lif...

Fireman Capital Partners

Fireman Capital Partners invests in consumer-focused companies through both growth equity and buyout transactions. The private equity firm focuses on dynamic consumer businesses with revenues between 30M USD and 150M USD, who also have a unique vision, strong product and market share, and sound management. FCP leverages its capital, extensive network, and ...

Friday 18th May 2018

Friends Committee on National Legislation (FCNL)

Land & Buildings Investment Management LLC

About Land & Buildings:

Palmer College of Chiropractic

Burlington Emergency & Veterinary Specialists

Since 1999, BEVS has had a unique and rich history caring for the companion animals of the Champlain Valley. It has evolved from a part-time ER service to today’s 24-hour advanced care facility. The team at BEVS proudly partners with primary care veterinarians throughout the region when emergency or specialty care is needed for companion animals. Addi...

Accent Therapeutics

Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By tar...


The team behind ClinicalStudio.EU dedicated more than four years to develop a suite of technology tools that radically cut the cost of research. By lowering the cost of research for scientific, medical, and academic communities, the high prices associated with healthcare can be reduced, ensuring more people benefit from new and improved medical discoveries...

Thursday 17th May 2018

Indee Labs

Indee Labs is developing hardware for gene delivery using microfluidic vortex shedding (µVS).

AmeriHealth Caritas and CleanSlate Centers

AmeriHealth Caritas District of Columbia, a member of the AmeriHealth Caritas Family of Companies, is a Medicaid managed care health plan dedicated to helping members get care, stay well and build healthy communities. Headquartered in the District, AmeriHealth Caritas District of Columbia addresses social risk factors impacting health, leverages robust mem...


Softchoice is one of the largest IT solution and managed service providers in North America. Every day, thousands of organizations rely on Softchoice to provide insight and expertise that speeds the adoption of technology, while managing cost and risk. Through our unique points of view, we challenge leaders to think differently about the impact of technolo...

Verastem Oncology

Verastem, Inc. (Nasdaq:VSTM), operating as Verastem Oncology, is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients. Verastem Oncology is currently developing duvelisib, a dual inhibitor of PI3K-delta and PI3K-gamma, which has successfully met its primary endpoint i...


More From BioPortfolio on ""

Quick Search